AIM
XBI icon

AHL Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

AHL Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-162
Closed -$18K – 309
2021
Q4 		$18K Buy
+162
New +$19.5K 0.02% 170

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

AHL Investment Management's XBI Position: Q1 2022 in Review

AHL Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 162 shares — an estimated $18K sold.

AHL Investment Management first reported a position in XBI in Q4 2021 and held it in 1 quarter. The position peaked at $18K in Q4 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

  • AHL Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
  • AHL Investment Management sold 162 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $18K.
  • AHL Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 1 quarter.
  • AHL Investment Management's State Street SPDR S&P Biotech ETF position peaked at $18K in Q4 2021.
  • 703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on AHL Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.